Venture Capital Investors

Harbour BioMed

Harbour BioMed is focused on investing in companies focused on high-impact, technology-driven solutions.

Venture Investor Overview

Contact Information

Background Information

Overview

Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology. The Company is building its robust portfolio and differentiated pipeline through internal R&D capability, collaborations with co-discovery and co-development partners and select acquisitions.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/26/2023

Transaction History

Our records indicate that Harbour BioMed invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Jingsong Wang

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Harbour BioMed has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Harbor Spring Capital | Harbour Point Capital

Share this article

About Our VC & M&A Database

This venture capital firm data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary